Cargando…
Comparing low-pass sequencing and genotyping for trait mapping in pharmacogenetics
BACKGROUND: Low pass sequencing has been proposed as a cost-effective alternative to genotyping arrays to identify genetic variants that influence multifactorial traits in humans. For common diseases this typically has required both large sample sizes and comprehensive variant discovery. Genotyping...
Autores principales: | Wasik, Kaja, Berisa, Tomaz, Pickrell, Joseph K., Li, Jeremiah H., Fraser, Dana J., King, Karen, Cox, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981957/ https://www.ncbi.nlm.nih.gov/pubmed/33743587 http://dx.doi.org/10.1186/s12864-021-07508-2 |
Ejemplares similares
-
Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays
por: Li, Jeremiah H., et al.
Publicado: (2021) -
Detection and interpretation of shared genetic influences on 42 human traits
por: Pickrell, Joseph K., et al.
Publicado: (2016) -
Assessment of Imputation from Low-Pass Sequencing to Predict Merit of Beef Steers
por: Snelling, Warren M., et al.
Publicado: (2020) -
Identifying genetic variants that affect viability in large cohorts
por: Mostafavi, Hakhamanesh, et al.
Publicado: (2017) -
Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study
por: Cohn, Iris, et al.
Publicado: (2017)